Chaudhary D, Hussain K, Semwal N, Ashok PK, Bhattrai M, Chaudhary B. A Review on Analytical Method Validation. J Adv Pharmacol. 2021;1(2):38–45.

Google Scholar 

Sharma S, Goyal S, Chauhan K. A review on analytical method development and validation. Int J Appl Pharm. 2018;10(6):8.

CAS  Google Scholar 

Kadian N, Raju KSR, Rashid M, Malik MY, Taneja I, Wahajuddin M. Comparative assessment of bioanalytical method validation guidelines for pharmaceutical industry. J Pharm Biomed Anal. 2016;126:83–97.

CAS  PubMed  Google Scholar 

Fekete S, Guillarme D, Sandra P, Sandra K. Chromatographic, Electrophoretic, and Mass Spectrometric Methods for the Analytical Characterization of Protein Biopharmaceuticals. Anal Chem. 2016;88(1):480–507.

CAS  PubMed  Google Scholar 

ICH Q2(R1) Validation of Analytical Procedures: Text and Methodology Guidance for Industry. U.S. Department of Health and Human Services Food and Drug Administration; 2005.

FDA. Analytical Procedures and Methods Validation for Drugs and Biologics. U.S. Food and Drug Administration; 2015.

FDA. Bioanalytical Method Validation Guidance for Industry. U.S. Food and Drug Administration; 2018.

Jesus JISDSD, Löbenberg R, Bou-Chacra NA. Raman Spectroscopy for Quantitative Analysis in the Pharmaceutical Industry. J Pharm Pharm Sci. 2020;23(1):24–46.

PubMed  Google Scholar 

Villaumié J, Andrews D, Geentjens K, Igne B, McGeorge G, Owen A, et al. Analytical Method Development Using Transmission Raman Spectroscopy for Pharmaceutical Assays and Compliance with Regulatory Guidelines—Part II: Practical Implementation Considerations. J Pharm Innov. 2019;14(3):245–58.

Google Scholar 

Sharif S, Khan IU, Ashfaq M, Iqbal MS, Ahmad S. Development and validation of a high performance liquid chromatographic method for the simultaneous determination of potassium clavulanate and cefadroxil in synthetically prepared tablets. J Anal Chem. 2010;65(10):1029–34.

CAS  Google Scholar 

Kurbanoglu S, Palabiyik BB, Gumustas M, Şanlı S, Uslu B, Ozkan SA. Development and validation of a stability-indicating rp-lc method for the determination of anticancer drug epirubicin in pharmaceuticals. J Liq Chromatogr Relat Technol. 2014;37(11):1583–96.

CAS  Google Scholar 

Peterson JJ, Snee RD, McAllister PR, Schofield TL, Carella AJ. Statistics in Pharmaceutical Development and Manufacturing. J Qual Technol. 2009;41(2):111–34.

Google Scholar 

Tome T, Žigart N, Časar Z, Obreza A. Development and Optimization of Liquid Chromatography Analytical Methods by Using AQbD Principles: Overview and Recent Advances. Org Process Res Dev. 2019;23(9):1784–802.

CAS  Google Scholar 

Prajapati P, Patel A, Shah S. DoE-Based Analytical Quality Risk Management for Enhanced AQbD Approach to Economical and Eco-Friendly RP-HPLC Method for Synchronous Estimation of Multiple FDC Products of Antihypertensive Drugs. J Chromatogr Sci. 2022;60(8):786–99.

CAS  PubMed  Google Scholar 

Prajapati PB, Radadiya K, Shah SA. Quality Risk Management Based: Analytical Quality by Design Approach to Eco-Friendly and Versatile Chromatography Method for Simultaneous Estimation of Multiple Fixed-Dose-Combination Products of Anti-Diabetic Drugs. J Pharm Innov. 2022;17(1):111–28.

Google Scholar 

Jensen WA. Confirmation Runs in Design of Experiments. J Qual Technol. 2016;48(2):162–77.

Google Scholar 

Prajapati PB, Patel PR, Shah SA. Chemometric and DoE-Based Analytical Quality Risk Management to HPTLC Method for Simultaneous Estimation of Metronidazole and Norfloxacin. J Chromatogr Sci. 2023;61(5):428–39.

CAS  PubMed  Google Scholar 

Ghaderi A, Hassani H, Khodaygan S. A Bayesian-reliability based multi-objective optimization for tolerance design of mechanical assemblies. Reliab Eng Syst Saf. 2021;213:107748.

Google Scholar 

Zhai G, Zhou Y, Ye X. A Tolerance Design Method for Electronic Circuits Based on Performance Degradation. Qual Reliab Eng Int. 2015;31(4):635–43.

Google Scholar 

Huang P, Li H, Gu Y, Qiu G, Ding Y. Experimental tolerance design of robot manipulators accounting for positioning accuracy reliability. Qual Reliab Eng Int. 2023;39(5):1573–87.

Google Scholar 

Shah JJ, Yan Y, Zhang BC. Dimension and tolerance modeling and transformations in feature based design and manufacturing. J Intell Manuf. 1998;9(5):475–88.

Google Scholar 

Rozet E, Hubert C, Ceccato A, Dewé W, Ziemons E, Moonen F, et al. Using tolerance intervals in pre-study validation of analytical methods to predict in-study results. J Chromatogr A. 2007;1158(1–2):126–37.

CAS  PubMed  Google Scholar 

Oshinbolu S, Wilson LJ, Lewis W, Shah R, Bracewell DG. Measurement of impurities to support process development and manufacture of biopharmaceuticals. TrAC Trends Anal Chem. 2018;101:120–8.

CAS  Google Scholar 

Nowatzke W, Woolf E. Best practices during bioanalytical method validation for the characterization of assay reagents and the evaluation of analyte stability in assay standards, quality controls, and study samples. AAPS J. 2007;9(2):E117–22.

CAS  PubMed  PubMed Central  Google Scholar 

Center for Drug Evaluation and Research (CDER). Reviewer Guidance, Validation of Chromatographic Methods. FDA Office of Enforcement; 1994.

ICH. Q6B Specifications: Test Procedures and Acceptance Criteria for Biotechnological/Biological Products. U.S. Department of Health and Human Services Food and Drug Administration; 1999.

ICH-Quality. Q9(R1) Quality Risk Management. U.S. Department of Health and Human Services Food and Drug Administration; 2023.

Govaerts B, Dewé W, Maumy M, Boulanger B. Pre-study analytical method validation: comparison of four alternative approaches based on quality-level estimation and tolerance intervals. Qual Reliab Eng Int. 2008;24(6):667–80.

Google Scholar 

Chen C, Wang H. Tolerance interval for the mixture normal distribution. J Qual Technol. 2020;52(2):145–54.

Google Scholar 

Kirkpatrick RL. Sample Sizes to Set Tolerance Limits. J Qual Technol. 1977;9(1):6–12.

Google Scholar 

Krause SO. PCMO L01–Setting Specifications for Biological Investigational Medicinal Products. PDA J Pharm Sci Technol. 2015;69(5):569–89.

CAS  PubMed  Google Scholar 

ICH. Q8(R2) Pharmaceutical Development. U.S. Department of Health and Human Services Food and Drug Administration; 2009.

Chavan AV, Gandhimathi R. Quality by Design Approach: Progress in Pharmaceutical method Development and Validation. Biomed Pharmacol J. 2023;16(3):1669–79.

CAS  Google Scholar 

Su H, Nelder JA, Wolbert P, Spence R. Application of generalized linear models to the design improvement of an engineering artefact. Qual Reliab Eng Int. 1996;12(2):101–12.

Google Scholar 

Besseris GJ. A methodology for product reliability enhancement via saturated–unreplicated fractional factorial designs. Reliab Eng Syst Saf. 2010;95(7):742–9.

Google Scholar 

Patra P, Katke S, Singh S, Panchal K, Johari A, Pawar AV, et al. Development and Evaluation of Stable Long Circulating Decitabine-loaded Copolymeric Nanoparticles: Harnessing QbD Approach and Lyophilization Technique. J Pharm Innov. 2024;19(3):38.

Google Scholar